JUSTIN JONES: Open Payments
NPI 1760547699 · PROVO, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$675 in 35 payments from 11 companies in 2025. Trend: 2023 $769 · 2024 $602 · 2025 $675
Food & beverage: $675
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 11 | $228 |
| Abbott Laboratories | 3 | $81 |
| GlaxoSmithKline, LLC. | 4 | $66 |
| PFIZER INC. | 3 | $52 |
| Lilly USA, LLC | 3 | $51 |
| Novo Nordisk Inc | 3 | $47 |
| Corcept Therapeutics | 2 | $45 |
| SANOFI PASTEUR INC. | 2 | $39 |
| Merck Sharp & Dohme LLC | 2 | $32 |
| Kowa Pharmaceuticals America, Inc. | 1 | $18 |
Products named: VRAYLAR, FREESTYLE LIBRE 3, QULIPTA, UBRELVY, SHINGRIX, Wegovy, Korlym, PREVNAR 20.
Industry payments across UT — which companies pay providers there.
